[News Focus] Samsung BioLogics’ alleged accounting fraud brings 2015 merger back under scrutiny
IndustryMay 11, 2018
Growing allegations that biopharma firm Samsung BioLogics fabricated financial statements, coupled with checks by authorities and activist shareholders, are bringing questions on a controversial deal between two Samsung affiliates back to the fore, according to market experts Friday.The Financial Services Commission plans to review the case of Samsung BioLogics next week via an oversight panel. The financial regulator is reportedly seeking clues on whether the change in accounting method was ass